Match Document Document Title
DE10004815B4 Human intestinal sodium phosphate cotransporter  
Npt2B polypeptide (I) having a 688 amino acid sequence (1), reproduced in the specification, is new. Independent claims are also included for the following: (1) Npt2B polypeptide (I') at least 90%...
DE69526973T3 SEQUENCES OF HEPATITIS C VIRUS GENOTYPE 7 AND THEIR USE AS PREVENTIVE, THERAPEUTIC AND DIAGNOSTIC AGENTS  
The present invention relates to HCV type 10 sequences. These HCV sequences are useful to diagnose the presence of HCV in a biological sample. Moreover, the availability of these type-specific...
DE102008029356A1 A method for purifying nucleic acids, in particular of fixed tissue  
The invention relates to a method for purification of nucleic acids, a kit for performing the inventive method, as well as a novel use of magnetic particles for purifying a biological sample. The...
DE102008025328A1 Detecting HIV in a blood sample comprises providing and optionally concentrating the sample, extracting viral nucleic acids, adding the extract to PCR master mix and performing amplification and detecting the amplified viral nucleic acids  
Method (A) for detecting HIV in a sample derived from blood comprises: (a) providing the sample derived from blood; (b) optionally concentrating the sample derived from blood; (c) extracting viral...
DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule  
Tetrahydro-pyran compounds (I) are new. Tetrahydro-pyran compounds of formula (I) are new. 3 of R 1-R 4= a leaving group comprising OAc and the other is OSO 2R', and R'= methyl, trifluoromethyl or...
DE19831609B4 A process for producing amino acids of the aspartate and / or glutamate family and used in the process means  
Microbial production of amino acids (A) of the asparate and/or glutamate families comprises increasing pyruvate carboxylase (PC) activity by genetic alteration of the enzyme and/or increasing...
DE102008023301A1 New nucleophilic cytosine derivatives and their applications  
The invention relates to the novel and not previously used in the synthesis of cytidines silylated cytosine analogs 4c and 4d as well as their use for reactions with 3,5-protected sugars of...
DE102008022017A1 Preparing 1,4-benzothiepin-1,1-dioxide derivative, comprises e.g. reacting mercaptomethyl-hexanol compound with difluorobenzoyl-azinic acid compound and converting into e.g. benzo(b)thiepin-4-ol compound followed by isolating and purifying  
Preparation of 1,4-benzothiepin-1,1-dioxide derivative (I), comprises e.g. reacting (S)-2-ethyl-2-mercaptomethyl-hexan-1-ol (V) with [3-(2,5-difluorobenzoyl)phenyl]azinic acid (VIII), followed by...
DE19937019B4 A method for producing 4-aryl-2-butanols from Taxus wallichiana  
A method for producing two 4-aryl-2-butanols with the general formula 1 wherein R = H or glucose is, from the leaves of Taxus wallichiana, comprising the steps of: (A) degreasing air-dried,...
DE10154290B4 A method for detecting periodontal disease and caries-associated bacteria  
The invention relates to the diagnosis of microorganisms, especially the detection of microorganisms which are associated with the disease known as parodontitis or tooth decay. The information...
DE102008017590A1 Glucopyranosidderivate  
New compounds of formula I whereinX has the meaning given in claim 1, useful as antidiabetic agents.
DE102005031755B4 Salmonella spp. binding peptides, nucleic acids encoding the Verwenduen and methods and kits for enrichment, immobilization and detection of Salmonella spp.  
Salmonella spp. binding peptide selected from the sequences SEQ ID NO. 1 to NO. 3, SEQ ID NO. 5 to NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14 to NO. 16, SEQ ID NO. 18, SEQ ID NO. 20 to NO....
DE69529276T2 TARGETED GENE THERAPY  
Nucleic acid constructs comprising at least one gene encoding a species having activity against disease, such as a pro-drug activation system, operatively linked to a hypoxically inducible...
DE102008012295A1 Mixture for the production of rapidly disintegrating tablets  
Isomalt-containing mixture, comprising a) 60-97 wt .-% agglomerated isomalt, b) 1-25 wt .-% cross-linked polyvinylpyrrolidone, c) 0.1-15 wt .-% lubricant, d) 1-15 wt. -% water-insoluble,...
DE102008012015A1 Improved isomalt-containing compressed formulations and methods for their preparation  
The present invention relates to improved isomalt-containing compacts and methods for their preparation.
DE602005005449T2 ADJUVANT COMPOSITIONS  
An adjuvant composition comprises a Th1-activating alkaloid, optionally further comprising an auxiliary adjuvant selected from a type 2 adjuvant (e.g. alum and/or MF59), a type 1 adjuvant and/or a...
DE102008010693A1 New matrix materials, to processes for their preparation and their use in methods for isolating biomolecules  
The present invention berifft functionalized matrix materials or matrices which have the structures of the general formula I Processes for their preparation and their use for purification and...
DE102008010584A1 Detecting anaerobic microorganisms capable of degrading aromatic compounds comprises using nucleotide sequences coding for a conserved amino acid sequence of 6-oxocyclohexene-1-carbonyl coenzyme A hydrolase  
Detecting anaerobic microorganisms that are capable of degrading aromatic compounds comprises contacting an environmental sample with nucleotide sequences coding for a conserved amino acid...
DE10084502B4 A method for purification of nucleic acid with silicon carbide  
The invention disclosed is particularly directed to a process for the purification of DNA, and is especially useful for the isolation of biologically active plasmid DNA. The process is initiated...
DE102008008270A1 Novel cyclic oxo-silanes based on sugar derivatives and process for their preparation  
Are given for the preparation thereof novel cyclic oxo-silanes based on sugar derivatives and methods. As part of the invention is, inter alia, succeeded in introducing silicon atoms at the...
DE102008008193A1 Roller- or plain bearing forgery-proof marking of a valuable document, comprises a bearing body with a surface, and a marking that enables a clear identification of the bearing body and comprises a synthetic nucleic acid  
The roller- or plain bearing (6) comprises a bearing body with a surface (1), and a marking that enables a clear identification of the bearing body and comprises a synthetic nucleic acid (4)...
DE102008006416A1 Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive aerobic germs  
Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive...
DE69433518T4 NUCLEIC THAT FOR A TUMOR ABSTOSSUNGSANTIGENVORLÄUFER CODED  
The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor...
DE102008000101A1 A process for obtaining D-galactose from vegetable raw material by acid hydrolysis  
Disclosed is a method for the recovery of D-galactose, comprising the steps of:- Providing an aqueous solution or suspension of Galactoarabinan, wherein the aqueous solution or phase has a pH of...
DE69331832T3 DIAGNOSTIC METHOD AND PHARMACEUTICAL COMPOSITIONS BASED ON NOTCH proteins and nucleic acids  
The present invention relates to pharmaceutical compositions comprising a fragment of a Delta protein or a derivative or analog of said fragment, or comprising a derivative or analog of a Delta...
DE102008054480A1 Direct sequencing by ATP release  
There is provided a method for sequencing a nucleic acid. In certain embodiments, the method comprises contacting a nucleic acid duplex comprising a template and a nucleic acid annealed to the...
DE68929299T3 Multiple genomic DNA amplification for the detection of a deletion  
The present invention relates to a method for detecting multiple DNA sequences simultaneously. The method involves amplification of multiple sequences simultaneously by annealing a plurality of...
DE69435096T2 COMPOSITION FOR IN VIVO PRODUCTION OF THERAPEUTIC PRODUCTS  
The present invention provides cell compositions for in vivo implantation, and designed for the sustained and controlled delivery of therapeutic substances.
DE602004013372T2 IL-7 FUSION PROTEIN WITH ANTIBODY PORTIONS, THE PRODUCTION AND USE THEREOF  
The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
DE69233402T3 NEW cytokines  
There is disclosed an isolated antibody immunoreactive with CD40-L or a CD40-L immunogen.
DE60038610T2 NEW CRYSTALLINE FORMS OF A macrolide antibiotic  
Novel crystalline forms of a compound of Formula 1 are disclosed:Also disclosed are pharmaceutical compositions comprising these forms, and methods of their preparation and use.
DE102007062962A1 New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg)  
The invention relates to sequences of a new mutant or variant of the hepatitis B surface antigen (HBsAg) and methods, these genomic and protein variant and antibodies directed against them from...
DE69334209T2 PROTEIN AN INDUCIBLE resistance to glycopeptides CAUSED, PARTICULARLY IN GRAM NEGATIVE BACTERIA  
The protein VanB of formula (I) (in Fig.) is new. (I) is implicated in Gram positive bacteria, in resistance to glycopeptides, partic. vancomycin (II), this resistance being inducible by (II) but...
DE69938507T2 Fragment of "connective tissue growth FACTOR" (CTGF)  
The present invention is directed to CTGF fragments comprising at least exon 2 or exon 3 of CTGF and having the ability to induce extracellular matrix synthesis, in particular, collagen synthesis...
DE69938567T2 METHOD FOR MARKING NUCLEIC  
The present invention relates to a process of fragmenting and labeling a synthetic or natural nucleic acid, comprising the steps of: providing a mixture containing a nucleic acid, a labeling agent...
DE69738637T2 Leptin receptor DB, THE RECEPTOR CODING NUCLEIC AND APPLICATIONS THEREOF  
The present invention relates to identification of a receptor for a satiety factor, which is involved in body weight homeostasis. Mutations in this receptor are associated with obese phenotypes....
DE60320302T2 METHOD FOR IDENTIFYING MODULATORS OF human orexin-2 RECEPTOR  
The present invention provides a new method for identifying modulators of human orexin-2 receptor without utilizing recombinantly produced nucleic acid molecules encoding human orexin receptor...
DE69738631T2 Endoglucanase from Thermotoga  
A thermostable glycosidase enzymes derived from various thermococcus, staphylothermus and pyrococcus organisms is disclosed. The enzymes are produced from native or recombinant host cells and can...
DE602004012840T2 4 '' - OR 4'-SUBSTITUTED avermectin and AVERMECTINMONOSACCHARIDDERIVATE WITH PESTICIDES PROPERTIES  
Disclosed are compounds of the formulain which n is 0 or 1; X-Y is -CH-CH- or -CH2-CH2-; Z is -C(-O)-, -C(-S)- or -SO2-; R1 is C1-C12alkyl, C3-C8cycloalkyl or C2-C12alkenyl; and R2 is R3-Z-,...
DE69738630T2 Human cancer antigen of the tyrosinase-like protein 1, and genes encoding for it  
The present invention discloses that the normal melanogenic gene, gp75 gene, encodes a gene product, a 24 amino acid peptide of ORF3, which is processed to an antigenic cancer peptide recognized...
DE69738586T2 HIGH EXPRESSION OF PROTEIN RATE  
The invention features a synthetic gene encoding a protein normally expressed in a mammalian cell wherein at least one non-preferred or less preferred codon in the natural gene encoding the...
DE102007052119A1 New coumermycin A1-derivative, useful as biologically active substance and as antibiotics or cytostatics, and for preventing diseases caused by bacteria or tumor  
Coumermycin A1-derivative (I), is new. Coumermycin A1-derivative of formula (I), is new. R1, R2 : CH 3, halo or H, preferably H, F, Cl, Br or I, where both R1, R2 are not simultaneously CH 3. An...
DE69738603T2 Method for generating libraries of complete cDNAs  
Disclosed is a method for making full-length cDNA libraries, which is for making libraries of cDNAs having lengths corresponding to full lengths of mRNAs and comprises the following steps of;...
DE10128250B4 Glykolipidderivate new, processes for their preparation and compositions comprising them  
The present invention is a compound of general formula (I) or a pharmaceutically acceptable salt of,wherein W represents carbon chain from 9 to 17 which containing double bond or hydroxy group...
DE69623473T3 Recombinant hexose OXIDASE, PROCESS FOR THEIR PRODUCTION AND USE  
A method of producing hexose oxidase by recombinant DNA technology, recombinant hexose oxidase and the use of such enzyme, in particular in the manufacturing of food products such as doughs and...
DE102008050273A1 Apparatus and method for synthesizing a biopolymer and method for recovering a reagent for synthesizing a biopolymer  
A Apparatus for synthesizing a biopolymer has a reaction chamber (100), an outlet (410b) connected to the reaction chamber (100) is connected, a plurality of recovery tanks (461A, 461C, 461g,...
DE69809362T3 Specially shaped maltitol, containing these crystalline compositions and methods for their preparation  
New crystalline maltitol forms containing: (a) bipyramidal; (b )prismatic; or (c) a mixture of bipyramidal and prismatic crystals. The bipyramidal-form crystals comprise regular octahedra of...
DE69637472T2 Recombinant vesiculoviruses AND THEIR USE  
The invention provides recombinant replicable vesiculoviruses. The invention provides a method which, for the first time, successfully allows the production and recovery of replicable...
DE202008016372U1 Vitamin containing composition  
vitamin containing composition, particularly suitable for nutritional accounted supplement food in inner ear disorders, said composition comprising as an effective Constituents substances...
DE19520398B4 Magnetic pigment  
reagent composition for isolating nucleic acids from a sample comprising (A) magnetic particles having a Glass surface, (B) a chaotropic salt solution, (C) optionally a washing solution and (D)...